Treatment
For MS now viable
Tyruko, a biosimilar
Providing a cost-effective
Alternative

#fda #ms #tyruko #biosimilar #tysabri #cinquain #poetry

http://www.medicalnewstoday.com/articles/fda-approves-first-natalizumab-biosimilar-for-ms-treatment